{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:37:16Z","timestamp":1787650636141,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41429-017-0024-9","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T12:49:18Z","timestamp":1518007758000},"page":"506-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae"],"prefix":"10.1038","volume":"71","author":[{"given":"Ni","family":"Wentao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guobao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Junchang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Zhancheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Youning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785\u201396.","journal-title":"Lancet Infect Dis."},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","volume":"25","author":"LS Tzouvelekis","year":"2012","unstructured":"Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25:682\u2013707.","journal-title":"Clin Microbiol Rev."},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","volume":"56","author":"ZA Qureshi","year":"2012","unstructured":"Qureshi ZA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56:2108\u201313.","journal-title":"Antimicrob Agents Chemother."},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis588","volume":"55","author":"M Tumbarello","year":"2012","unstructured":"Tumbarello M, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943\u201350.","journal-title":"Clin Infect Dis."},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"ofv050","DOI":"10.1093\/ofid\/ofv050","volume":"2","author":"HJ Morrill","year":"2015","unstructured":"Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis. 2015;2:ofv050.","journal-title":"Open Forum Infect Dis."},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1016\/S0924-8579(09)70005-6","volume":"32","author":"LR Peterson","year":"2008","unstructured":"Peterson LR. A review of tigecycline\u2013the first glycylcycline. Int J Antimicrob Agents. 2008;32:S215\u20132S22.","journal-title":"Int J Antimicrob Agents."},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"S388","DOI":"10.1093\/cid\/ciu594","volume":"59","author":"JM Pogue","year":"2014","unstructured":"Pogue JM, et al. Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clin Infect Dis. 2014;59:S388\u201393.","journal-title":"Clin Infect Dis."},{"key":"24_CR8","first-page":"e00073","volume":"61","author":"D Huang","year":"2017","unstructured":"Huang D, et al. In vitro assessment of combined polymyxin B and minocycline therapy against Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Antimicrob Agents Chemother. 2017;61:e00073\u201317.","journal-title":"Antimicrob Agents Chemother."},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1086\/338571","volume":"185","author":"X Zhao","year":"2002","unstructured":"Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. J Infect Dis. 2002;185:561\u20135.","journal-title":"J Infect Dis"},{"key":"24_CR10","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-sixth Inf Suppl. 2016;M100:S26."},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/ja.2013.84","volume":"66","author":"W Ni","year":"2013","unstructured":"Ni W, et al. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. J Antibiot. 2013;66:705\u20138.","journal-title":"J Antibiot."},{"key":"24_CR12","first-page":"1","volume-title":"Synergism testing: broth microdilution checkerboard and broth macrodilution method in Clinical Microbiology Procedures Handbook","author":"J Moody","year":"2004","unstructured":"Moody J. Synergism testing: broth microdilution checkerboard and broth macrodilution method in Clinical Microbiology Procedures Handbook. Washington, DC: ASM; 2004; p. 1\u201328."},{"key":"24_CR13","first-page":"330","volume-title":"Antibiotic in Laboratory Medicine","author":"GM Eliopoulos","year":"1996","unstructured":"Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotic in Laboratory Medicine. 4th edn. Baltimore: Williams and Wilkins; 1996; p. 330\u201396.","edition":"4th edn"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s40265-016-0636-6","volume":"76","author":"SL Greig","year":"2016","unstructured":"Greig SL, Scott LJ. Intravenous minocycline: a review in Acinetobacter infections. Drugs. 2016;76:1467\u201376.","journal-title":"Drugs."},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"S374","DOI":"10.1093\/cid\/ciu613","volume":"59","author":"DJ Ritchie","year":"2014","unstructured":"Ritchie DJ, Garavaglia-Wilson A. A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. Clin Infect Dis. 2014;59:S374\u2013S380.","journal-title":"Clin Infect Dis."},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1099\/jmm.0.000147","volume":"64","author":"CH Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez CH, Nastro M, Vay C, Famiglietti A. In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates. J Med Microbiol. 2015;64:1196\u20131200.","journal-title":"J Med Microbiol."},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1128\/AAC.02994-15","volume":"60","author":"YS Yang","year":"2016","unstructured":"Yang YS, et al. In vivo and in vitro efficacy of minocycline-based combination therapy for minocycline-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60:4047\u201354.","journal-title":"Antimicrob Agents Chemother."},{"key":"24_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep31964","volume":"6","author":"CC Lai","year":"2016","unstructured":"Lai CC, Chen CC, Huang HL, Chuang YC, Tang HJ. The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study. Sci Rep. 2016;6:31964.","journal-title":"Sci Rep."},{"key":"24_CR19","unstructured":"Tang, HJ et al. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: combination of tigecycline or doxycycline and gentamicin or amikacin. J Microbiol Immunol Infect. 2016;31:pii: S1684-1182 444 30024-X"},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1086\/321841","volume":"33","author":"X Zhao","year":"2001","unstructured":"Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis. 2001;33:S147\u201356.","journal-title":"Clin Infect Dis."},{"key":"24_CR21","first-page":"202818","volume":"2013","author":"KM Matar","year":"2013","unstructured":"Matar KM, Al-lanqawi Y, Abdul-Malek K, Jelliffe R. Amikacin population pharmacokinetics in critically ill Kuwaiti patients. Biomed Res Int. 2013;2013:202818.","journal-title":"Biomed Res Int."},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jac\/dkv291","volume":"71","author":"C Roger","year":"2016","unstructured":"Roger C, et al. Impact of 30\u2009mg\/kg amikacin and 8\u2009mg\/kg gentamicin on serum concentrations in critically ill patients with severe sepsis. J Antimicrob Chemother. 2016;71:208\u201312.","journal-title":"J Antimicrob Chemother."},{"key":"24_CR23","volume-title":"Minocin (minocycline for injection) Package Insert","author":"Rempex Pharmaceuticals, Inc.","year":"2010","unstructured":"Rempex Pharmaceuticals, Inc. Minocin (minocycline for injection) Package Insert. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2010."},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1515\/hsz-2013-0292","volume":"395","author":"F Nguyen","year":"2014","unstructured":"Nguyen F, et al. Tetracycline antibiotics and resistance mechanisms. Biol Chem. 2014;395:559\u201375.","journal-title":"Biol Chem."},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/cr0301088","volume":"105","author":"S Magnet","year":"2005","unstructured":"Magnet S, Blanchard JS. Molecular insights into aminoglycoside action and resistance. Chem Rev. 2005;105:477\u201398.","journal-title":"Chem Rev."},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/dkl172","volume":"58","author":"RE Crist\u00f3bal de","year":"2006","unstructured":"de Crist\u00f3bal RE, Vincent PA, Salom\u00f3n RA. Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli. J Antimicrob Chemother. 2006;58:31\u201336.","journal-title":"J Antimicrob Chemother."},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/14787210.2017.1316193","volume":"15","author":"AP Zavascki","year":"2017","unstructured":"Zavascki AP, Klee BO, Bulitta JB. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility. Expert Rev Anti Infect Ther. 2017;15:519\u201326.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1586\/eri.10.38","volume":"8","author":"M Cassone","year":"2010","unstructured":"Cassone M, Otvos L Jr. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev Anti Infect Ther. 2010;8:703\u201316.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00284-014-0529-4","volume":"68","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates. Curr Microbiol. 2014;68:685\u201392.","journal-title":"Curr Microbiol."},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s10096-017-2987-7","volume":"36","author":"P Morici","year":"2017","unstructured":"Morici P, et al. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains. Eur J Clin Microbiol Infect Dis. 2017;36:1739\u201348.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"24_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijantimicag.2016.07.018","volume":"48","author":"X Liu","year":"2016","unstructured":"Liu X, et al. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic\/pharmacodynamic model. Int J Antimicrob Agents. 2016;48:559\u201363.","journal-title":"Int J Antimicrob Agents."},{"key":"24_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ijantimicag.2017.01.007","volume":"49","author":"X Cai","year":"2017","unstructured":"Cai X, et al. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model. Int J Antimicrob Agents. 2017;49:609\u201316.","journal-title":"Int J Antimicrob Agents."},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/jac\/dkx130","volume":"72","author":"J Yim","year":"2017","unstructured":"Yim J, et al. Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs). J Antimicrob Chemother. 2017;72:2290\u20136.","journal-title":"J Antimicrob Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-017-0024-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-017-0024-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-017-0024-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:30:47Z","timestamp":1684618247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-017-0024-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1038\/s41429-017-0024-9","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compilance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}